This inventor holds 1 USPTO granted patent and 16 published patent applications. Top assignee: Recode Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Rumpa Bhattacharjee: Innovator in Targeted Delivery Systems
Introduction
Rumpa Bhattacharjee is a notable inventor based in Menlo Park, California. She has made significant contributions to the field of targeted delivery systems, particularly in the development of compositions and methods that enhance the delivery of therapeutic agents to specific cell types.
Latest Patents
Rumpa Bhattacharjee holds a patent for "Compositions and methods for targeted delivery to cells." This patent describes innovative compositions, kits, and methods designed for potent delivery to various cell types, including basal cells, ciliated cells, and secretory cells. Notably, the patent emphasizes the delivery to lung cells of specific types. The invention also includes pharmaceutical compositions that combine therapeutic or prophylactic agents with lipid compositions, which may consist of ionizable cationic lipids, phospholipids, and selective organ-targeting lipids. Furthermore, it outlines high-potency dosage forms of therapeutic agents formulated with lipid compositions.
Career Highlights
Rumpa Bhattacharjee is currently associated with Recode Therapeutics, Inc., where she continues to advance her research and innovations in targeted delivery systems. Her work is pivotal in developing new therapeutic strategies that can significantly impact patient care.
Collaborations
Rumpa collaborates with esteemed colleagues, including Mirko Hennig and Jackson Eby, to further enhance the research and development of targeted delivery methods.
Conclusion
Rumpa Bhattacharjee's contributions to the field of targeted delivery systems exemplify her innovative spirit and dedication to improving therapeutic outcomes. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile